Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

65.53
BATS BZX Real-Time Price
As of 9:36am ET
 -0.18 / -0.27%
Today’s Change
46.86
Today|||52-Week Range
65.83
+22.42%
Year-to-Date

Today’s Trading

Previous close65.71
Today’s open65.69
Day’s range65.47 - 65.69
Volume420
Average volume (3 months)2,205,007
Market cap$32.1B
Dividend yield0.64%
Data as of 9:36am ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+19.18%
Earnings growth (next 5 years)+14.50%
Revenue growth (last year)+2.58%
P/E ratio37.1
Price/Sales5.46
Price/Book21.78

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.54+0.38%
BAXBaxter International...-0.14-0.22%
INCYIncyte Corp+0.33+0.28%
VRTXVertex Pharmaceutica...+0.29+0.19%
Data as of 9:36am ET, 10/17/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts